![rheuma-online.at: Blockade von TNF-alpha: Ein erfolgsversprechender Ansatz bei der Therapie rheumatischer Erkrankungen rheuma-online.at: Blockade von TNF-alpha: Ein erfolgsversprechender Ansatz bei der Therapie rheumatischer Erkrankungen](https://www.rheuma-online.at/fileadmin/_migrated/pics/tnf-alpha.jpg)
rheuma-online.at: Blockade von TNF-alpha: Ein erfolgsversprechender Ansatz bei der Therapie rheumatischer Erkrankungen
![Frontiers | Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both? Frontiers | Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both?](https://www.frontiersin.org/files/Articles/591365/fimmu-11-591365-HTML-r2/image_m/fimmu-11-591365-g003.jpg)
Frontiers | Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both?
![The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era | Rheumatology International The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era | Rheumatology International](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00296-022-05136-x/MediaObjects/296_2022_5136_Fig1_HTML.png)
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era | Rheumatology International
![Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases](https://f6publishing.blob.core.windows.net/10648604-e5bd-4b72-b735-04fae698f690/WJG-22-9300-g002.jpg)
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
![Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aat3356/asset/0404e282-2d5e-4318-b333-29d3d1fc07f0/assets/graphic/aat3356-f1.jpeg)